Organization Overview
Alternative names
conjugated equine estrogens (1999)
danaparoid sodium (orgaran) (1996 NDA)
desogestrel (Mercilon) (2000)
Atrophy (Phase 2)
Embolism (Phase 4)
Injection Site Reaction (Phase 4)
Pulmonary Embolism (Phase 4)
Thrombocytopenia (Phase 3)
Thrombosis (Phase 4)
Venous Thrombosis (Phase 4)